Latest papers

Polypyrrole solid phase microextraction: A new approach to rapid sample preparation for the monitoring of antibiotic drugs.

The synthesis of novel fluorescent purine analogues modified by azacrown ether at C6.

Cascade cyclization to produce a series of fused, aromatic molecules.

Preliminary studies into the inhibition of the cholesterol alpha-glucosyltransferase from Helicobacter pylori using azasugars.

Synthesis of C-4'truncated phosphonated carbocyclic 2'-oxa-3'-azanucleosides as antiviral agents.

Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses.

Inguinal panniculitis in a young Tasmanian devil (Sarcophilus harrisii) caused by Mycobacterium mageritense.

Comparing the effectiveness of moxifloxacin and povidone-iodine with povidone-iodine alone.

Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.

Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.

Revisit the combination validation test of Tsong et al. for thorough QT/QTc clinical trials.

Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.

Thorough QT study of the effect of fesoterodine on cardiac repolarization.

Solvent-free microwave-assisted peroxidative oxidation of secondary alcohols to the corresponding ketones catalyzed by copper(ii) 2,4-alkoxy-1,3,5-triazapentadienato complexes.

Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death.

A divergent mechanistic course of Pd(0)-catalyzed aza-Claisen rearrangement and aza-Rautenstrauch-type cyclization of N-allyl ynamides.

Aminocatalytic asymmetric inverse-electron-demand aza-Diels-Alder reaction of N-Ts-1-aza-1,3-butadienes based on coumarin cores.

Helical chiral 2-aminopyridinium ions: a new class of hydrogen bond donor catalysts.

[Efficacy of moxifloxacin in treating bacterial conjunctivitis: a meta-analysis]

Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.